Search

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

… Thursday, September 6, 2018 Summary Research conducted at MSK has shown that more than 20% of people with a type of kidney cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations. This number is much higher than expected. Kidney cancer , also

The global clinical research community is facing a clear imperative to move beyond traditional manual data management methods in order to improve data capture, integrity, and exchange, while pursuing other related efficiencies.

… Tuesday, January 14, 2025 The global clinical research community is facing a clear imperative to move beyond traditional manual data management methods in order to improve data capture, integrity, and exchange, while pursuing other related efficiencies. Memorial Sloan Kettering Cancer Center (MSK) has

Vivian Strong, MD, FACS, the Iris Cantor Chair, addressed colleagues and gastric cancer experts from around the world at the International Gastric Cancer Congress 2022.

… Wednesday, March 30, 2022 Vivian Strong, MD, FACS , the Iris Cantor Chair, addressed colleagues and gastric cancer experts from around the world at the International Gastric Cancer Congress 2022 . Dr. Strong presented “Highlights of What is New in Surgery for Gastric Cancer” as part of the meeting’s

Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.

… Saturday, January 1, 2011 Summary Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine. Zvi Fuks has been elected a member of the Institute of Medicine (IOM), one of the highest honors in the fields of health and medicine. Dr.

A vital part of MSK's mission is to get patients back to feeling like themselves.

… Wednesday, July 12, 2017 VIDEO | 01:35 MSK's Dental Service Aims to Make People Whole Again Medical artist Marjorie Golden and Dental Service Chief Joseph Huryn create lifelike facial prostheses for patients. Video Details Summary A vital part of MSK’s mission is to get patients back to feeling like

MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible.

… Tuesday, April 16, 2024 MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible. “Traditionally, radical nephroueterectomy has been the gold standard for managing high-risk UTUC,” said  urologic surgeon Jonathan Coleman

An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects.

… Wednesday, May 10, 2023 Michael Szczerbienski had always been blessed with good health, so the day he found blood in his urine , he was quite alarmed. His doctor sent him for a CT scan , which revealed a tumor on his left kidney. Michael, whose kidney cancer was already advanced, went to Memorial Sloan

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.

… Tuesday, June 9, 2020 As part of the Memorial Sloan Kettering – Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers can apply for funding to support innovative investigations to explore the power of

An antibody that targets a prostate cell protein shows potential for designing safer, more effective prostate cancer therapies.

… Tuesday, April 24, 2018 Summary Current prostate cancer drugs often lose their effectiveness over time. A new approach involves using an antibody to deliver toxic radioactive particles selectively to prostate cancer cells. There are many effective prostate cancer drugs, but a major challenge is that

An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.

… Friday, April 1, 2011 Summary An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract. An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown that antibiotics